Sun Pharma Advanced Research Company Limited (NSE:SPARC)
India flag India · Delayed Price · Currency is INR
212.50
+1.91 (0.91%)
Nov 12, 2026, 3:30 PM IST

NSE:SPARC Revenue

Sun Pharma Advanced Research Company had revenue of 300.30M INR in the quarter ending September 30, 2026, with 282.06% growth. This brings the company's total for the last twelve months to 19.32B, up 3,141.19% year-over-year. In the fiscal year ending March 31, 2026, Sun Pharma Advanced Research Company had annual revenue of 18.79B with 2,518.47% growth. That makes Sun Pharma Advanced Research Company the 17,279th largest company in the world by revenue and 939th in India.

Revenue (ttm)
19.32B
Revenue Growth
+3,141.19%
P/S Ratio
3.53
Revenue / Employee
69.23M
Employees
279
Market Cap
68.96B

Revenue Chart

Revenue by Geography

  • India 380.49M 97.2%
  • Outside India 11.00M 2.8%
Fiscal year ended Mar 31, 2026 See the full NSE:SPARC breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202618.79B18.07B2,518.47%
Mar 31, 2025717.66M-37.79M-5.00%
Mar 31, 2024755.45M-1.63B-68.36%
Mar 31, 20232.39B1.02B73.98%
Mar 31, 20221.37B-1.16B-45.74%
Mar 31, 2021 Pro Pro Pro
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.